I have severe depression, anxiety, and panic attacks and am currently taking bupropion 300 mg daily, quetiapine 100 mg twice daily, and prazosin 1 mg twice nightly; what medication and management recommendations do you suggest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Current Regimen Assessment and Recommendations

Your current medication regimen requires optimization: add an SSRI or SNRI as first-line treatment for your severe depression and anxiety, closely monitor for treatment response within 1-2 weeks, and consider cognitive behavioral therapy (CBT) as an equally effective alternative or adjunct to pharmacotherapy.

Why Your Current Regimen Needs Adjustment

Your current combination—bupropion 300mg daily, quetiapine 200mg daily (100mg twice daily), and prazosin 2mg nightly—is not aligned with evidence-based first-line treatment for severe depression with anxiety and panic attacks.

The Bupropion Issue

While bupropion is FDA-approved for depression, it is not a first-line choice when severe anxiety and panic attacks are prominent features 1. The evidence shows:

  • Bupropion has comparable anxiolytic efficacy to SSRIs in patients with mild to moderate anxiety symptoms in depression 2, 3
  • However, in patients with high baseline anxiety (which you have with panic attacks), SSRIs show a modest but clinically meaningful advantage over bupropion 3
  • Bupropion's stimulating, activating properties can provoke or worsen anxiety, particularly at your current 300mg dose 4, 5
  • One small study suggested bupropion may help panic disorder 6, but this contradicts clinical experience and lacks robust replication

The Quetiapine Consideration

Quetiapine 200mg daily is being used off-label here. While it has shown efficacy for anxiety symptoms in bipolar depression 7, and guidelines list atypical antipsychotics like quetiapine as options for treatment-resistant cases 8, it should not be a first-line agent for primary depression with anxiety 8. The insomnia guideline specifically notes quetiapine is "only suitable for patients with comorbid insomnia who may benefit from the primary action of these drugs" 8.

The Prazosin Component

Prazosin 2mg nightly is typically used for PTSD-related nightmares. Recent evidence suggests low-dose prazosin (0.5-1mg) may help depression with trauma history 9, but your dose is higher and this is not standard first-line treatment. If you have trauma history with nightmares, continuing prazosin is reasonable, but monitor for orthostatic hypotension (16.7% incidence) 9.

Recommended Treatment Algorithm

Step 1: Add or Switch to an SSRI or SNRI

The American College of Physicians strongly recommends selecting second-generation antidepressants based on adverse effect profiles, cost, and patient preferences 1. For severe depression with anxiety and panic attacks, SSRIs are the evidence-based first choice:

Preferred options:

  • Sertraline 25-50mg daily initially, titrate to 200mg daily - well-tolerated, less drug interactions than other SSRIs, effective for both depression and panic disorder 4
  • Escitalopram 10mg daily, titrate to 20mg daily - well-tolerated, fewer side effects
  • Paroxetine 10mg daily, titrate to 40mg - less activating but more anticholinergic and higher sexual dysfunction rates 1

Critical monitoring: Assess treatment response, adverse effects, and suicidal ideation within 1-2 weeks of starting, then regularly 1. SSRIs carry increased risk for nonfatal suicide attempts compared to placebo (odds ratio 1.57-2.25) 1, requiring close monitoring especially in the first 1-2 months.

Step 2: Taper Bupropion or Continue Based on Response

Option A (Preferred): Switch from bupropion to SSRI

  • Taper bupropion over 10-14 days to minimize withdrawal 4
  • This eliminates the potentially anxiety-provoking stimulant effect

Option B: Continue bupropion alongside SSRI if:

  • You've had good response to bupropion for depression (just not anxiety)
  • You want to avoid SSRI sexual side effects (bupropion has significantly lower rates) 1
  • You're willing to accept combination therapy complexity

Step 3: Reassess Quetiapine

Taper and discontinue quetiapine once SSRI reaches therapeutic dose, unless:

  • You have severe insomnia unresponsive to other interventions 8
  • You have bipolar disorder (not mentioned in your question)
  • You reach Step 4 below

The quetiapine is likely providing sedation but adds metabolic risks (weight gain, diabetes) without addressing the core pathophysiology of your depression and anxiety.

Step 4: If Inadequate Response at 6-8 Weeks

Modify treatment if inadequate response after 6-8 weeks on adequate SSRI dose 1. Options include:

Augmentation strategies (evidence of moderate certainty for similar efficacy) 10:

  • Add bupropion SR 150mg twice daily (if you discontinued it earlier) 1
  • Add buspirone 5mg twice daily, titrate to 20mg three times daily 4
  • Add low-dose quetiapine 50-300mg at bedtime 8, 7, 11
  • Add aripiprazole or brexpiprazole (atypical antipsychotics with better metabolic profiles) 11

Switch strategies:

  • Switch to different SSRI or SNRI (venlafaxine, duloxetine)
  • Evidence shows similar efficacy among various switch strategies 10

Step 5: Add Cognitive Behavioral Therapy

CBT is supported by moderate-certainty evidence to achieve similar treatment effects as antidepressants 10. For panic attacks specifically, CBT with exposure therapy is highly effective. CBT should be:

  • Started alongside medication, not delayed
  • Continued even if medications are working (facilitates eventual medication taper) 8
  • Prioritized if you prefer non-pharmacologic approaches

Prazosin Decision

Continue prazosin 2mg nightly if:

  • You have trauma history with nightmares/sleep disturbances
  • You're tolerating it without significant orthostatic hypotension
  • Recent evidence supports benefit in depression with trauma 9

Discontinue or reduce to 0.5-1mg if:

  • No trauma history or nightmares
  • Experiencing dizziness or orthostatic symptoms
  • Lower doses (0.5-1mg) showed efficacy in recent trial 9

Critical Pitfalls to Avoid

  1. Don't wait beyond 6-8 weeks to modify treatment if response is inadequate 1. About 38% don't respond and 54% don't achieve remission with initial antidepressant 1.

  2. Don't abruptly stop antidepressants - taper over 10-14 days minimum 4

  3. Don't assume bupropion worsens all anxiety - it can help mild-moderate anxiety in depression 2, 3, but your severe anxiety with panic attacks needs SSRI first-line treatment

  4. Don't use quetiapine as first-line - reserve for augmentation after SSRI trial 8, 11

  5. Monitor closely for suicidal ideation - highest risk in first 1-2 months of antidepressant treatment 1

Bottom Line

Start an SSRI (sertraline 25-50mg or escitalopram 10mg), maintain close monitoring, consider tapering bupropion if anxiety worsens, plan to discontinue quetiapine once SSRI is therapeutic, continue prazosin if trauma-related symptoms exist, and add CBT regardless of medication choices 1, 10.

References

Research

Bupropion and Anxiety: A Brief Review.

Human psychopharmacology, 2025

Research

Bupropion sustained release for panic disorder.

Psychopharmacology bulletin, 2003

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Related Questions

A patient taking escitalopram (Cipralex) and bupropion experienced worsening anxiety; after stopping bupropion for five days, how long should improvement be expected?
Can bupropion be used to treat anxiety?
Can bupropion (Wellbutrin) cause increased anxiety and shortness of breath, and what is the typical duration of a 24‑hour panic episode?
What is the appropriate initiation, titration, and monitoring plan for bupropion maintenance therapy in a 27-year-old woman with mixed anxiety and depressive disorder?
In a 59-year-old female nursing-home resident with depression, anxiety, and a history of alcohol abuse who is taking bupropion XL (bupropion) 300 mg daily, escitalopram 20 mg daily, trazodone 100 mg at bedtime and 25 mg in the morning, amphetamine/dextroamphetamine (Adderall) 10 mg daily, and divalproex sodium (Depakote) 250 mg twice daily, and who now presents with worsening depression, social isolation, increased daytime sleepiness, and anhedonia, what is the optimal psychotropic treatment approach?
What can be added to a patient who is experiencing fatigue while taking only buspirone (Buspar)?
What is the appropriate management for lower pelvic pain?
What are the side effects of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs)?
What are the current guidelines for low‑dose aspirin (81 mg daily) prophylaxis in adults aged 40–70 years with ≥10 % 10‑year atherosclerotic cardiovascular disease risk and no contraindications to bleeding?
How should the laboratory results be interpreted for a 73-year-old woman who, one week after knee replacement surgery, experiences brief episodes of positional light‑headedness resembling motion sickness with mild gastrointestinal upset, denies chest pain, dyspnea, true vertigo, fever, or neurological deficits, and is taking metoprolol and acetaminophen (Tylenol) with occasional meclizine or dimenhydrinate?
What is the recommended evaluation and management for a patient with persistent dorsal pain and swelling two months after a fall, worsened by range of motion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.